<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="/sponet/themes/root/assets/xsl/rss.xsl"?>
<rss version="2.0" xmlns:opensearch="http://a9.com/-/spec/opensearch/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/">
  <channel>
    <title>Ergebnis für Versionen - 4027050</title>
    <description>Treffer 1 - 2 von 2</description>
    <generator>Laminas_Feed_Writer 2 (https://getlaminas.org)</generator>
    <link>https://sponet.de/sponet/Search/Versions?sort=first_indexed+desc%2Cfirst_indexed+desc&amp;limit=50&amp;id=4027050&amp;search=versions&amp;lng=de</link>
    <opensearch:totalResults>2</opensearch:totalResults>
    <opensearch:startIndex>0</opensearch:startIndex>
    <opensearch:itemsPerPage>50</opensearch:itemsPerPage>
    <opensearch:Query role="request" searchTerms="4027050" startIndex="0"/>
    <atom:link rel="first" type="application/rss+xml" title="Zur ersten Seite springen" href="https://sponet.de/sponet/Search/Versions?sort=first_indexed+desc%2Cfirst_indexed+desc&amp;limit=50&amp;view=rss&amp;id=4027050&amp;search=versions&amp;lng=de"/>
    <atom:link rel="last" type="application/rss+xml" title="Zur letzten Seite springen" href="https://sponet.de/sponet/Search/Versions?sort=first_indexed+desc%2Cfirst_indexed+desc&amp;limit=50&amp;view=rss&amp;id=4027050&amp;search=versions&amp;lng=de&amp;page=1"/>
    <atom:link rel="self" type="application/rss+xml" href="https://sponet.de/sponet/Search/Versions?sort=first_indexed+desc%2Cfirst_indexed+desc&amp;limit=50&amp;view=rss&amp;id=4027050&amp;search=versions&amp;lng=de"/>
    <item>
      <title>Die Grenzen der akzeptablen biologischen Variation bei Leistungssportlern: Sollte eine Geschlechtsambiguität anders als andere genetische Vorteile behandelt werden?</title>
      <pubDate>Sun, 01 Jan 2012 13:48:31 +0100</pubDate>
      <link>https://sponet.de/sponet/Record/4027050</link>
      <guid>https://sponet.de/sponet/Record/4027050</guid>
      <author>Bostwick, J. M.</author>
      <author>Joyner, M. J.</author>
      <dc:format>Artikel</dc:format>
      <dc:subject>Genetik</dc:subject>
      <dc:subject>Geschlecht</dc:subject>
      <dc:subject>weiblich</dc:subject>
      <dc:subject>männlich</dc:subject>
      <dc:subject>Hochleistungssport</dc:subject>
      <dc:subject>Leistungssport</dc:subject>
      <dc:subject>Leistungsfaktor</dc:subject>
      <dc:format>Artikel</dc:format>
      <dc:creator>Bostwick, J. M.</dc:creator>
      <dc:creator>Joyner, M. J.</dc:creator>
      <content:encoded><![CDATA[Elite athletes are unlike other people. They are gifted with the ability to be able to work their bodies faster, harder, and more skillfully than "mere mortals." While the exercise of prodigious discipline is undoubtedly key to their successes, genetic and other biological variants likely factor into world-class performances, although how they do so is both complicated and poorly understood. In this context, disorders of sexual differentiation (DSDs) can sometimes give female competitors a masculine edge. As the 2012 Olympic Games approach, one such athlete, Caster Semenya, a middle-distance runner from South Africa, has been cleared to compete, although not without considerable controversy that triggered an extensive medical work-up ordered by the International Association of Athletics Federations (IAAF) that confirmed a DSD and judged her to be a woman for the purpose of competition.]]></content:encoded>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Die Grenzen zu akzeptierender biologischer Variationen bei Leistungssportlern: Sollte sexuelle Ambiguität anders als andere zu Vorteilen führende genetische Züge behandelt werden?</title>
      <pubDate>Sun, 01 Jan 2012 13:48:31 +0100</pubDate>
      <link>https://sponet.de/sponet/Record/4025427</link>
      <guid>https://sponet.de/sponet/Record/4025427</guid>
      <author>Boswick, J. M.</author>
      <author>Joyner, M. J</author>
      <dc:format>Artikel</dc:format>
      <dc:subject>Genetik</dc:subject>
      <dc:subject>Geschlecht</dc:subject>
      <dc:subject>weiblich</dc:subject>
      <dc:subject>männlich</dc:subject>
      <dc:subject>Wettkampfbestimmung</dc:subject>
      <dc:subject>international</dc:subject>
      <dc:subject>Leistungsfähigkeit</dc:subject>
      <dc:format>Artikel</dc:format>
      <dc:creator>Boswick, J. M.</dc:creator>
      <dc:creator>Joyner, M. J</dc:creator>
      <content:encoded><![CDATA[Elite athletes are unlike other people. They are gifted with the ability to be able to work their bodies faster, harder, and more skillfully  than "mere mortals." While the exercise of prodigious  discipline is undoubtedly key to their successes, genetic and other biological variants likely factor into world-class performances, although how they do so is both complicated and poorly understood. In this context, disorders of sexual differentiation (DSDs) can sometimes give female competitors a masculine edge. As the 2012 Olympic Games approach, one such athlete, Caster Semenya, a  middle-distance  runner from South Africa, has been cleared to compete, although not without considerable controversy that triggered an extensive medical work-up ordered by the International Association of Athletics Federations (IAAF) that confirmed a DSD and judged her to be a woman for the purpose of competition.]]></content:encoded>
      <slash:comments>0</slash:comments>
    </item>
  </channel>
</rss>
